Quest Diagnostics Incorporated
DGX
$190.18
$0.370.20%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.17% | -0.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.17% | -0.36% | |||
| Cost of Revenue | 3.17% | 1.39% | |||
| Gross Profit | 3.17% | -3.79% | |||
| SG&A Expenses | 2.47% | -1.02% | |||
| Depreciation & Amortization | 0.00% | -5.13% | |||
| Other Operating Expenses | -- | -100.00% | |||
| Total Operating Expenses | 2.90% | 0.75% | |||
| Operating Income | 4.85% | -6.67% | |||
| Income Before Tax | 0.30% | 0.30% | |||
| Income Tax Expenses | -8.64% | 5.19% | |||
| Earnings from Continuing Operations | 3.13% | -1.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -9.09% | 21.43% | |||
| Net Income | 2.86% | 0.00% | |||
| EBIT | 4.85% | -6.67% | |||
| EBITDA | 3.91% | -4.45% | |||
| EPS Basic | 3.38% | 1.73% | |||
| Normalized Basic EPS | 2.27% | -5.25% | |||
| EPS Diluted | 1.84% | 1.83% | |||
| Normalized Diluted EPS | 1.35% | -5.26% | |||
| Average Basic Shares Outstanding | -0.90% | -0.89% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.88% | |||
| Dividend Per Share | 7.50% | 0.00% | |||
| Payout Ratio | -0.05% | 0.01% | |||